Use of Marstacimab for Prophylaxis in hemophilia A and B; matched-donor allogeneic CD19 CAR-T in adult B-ALL; a new prognostic index for T-cell cutaneous lymphomas
This Blood Podcast episode discusses marstacimab for hemophilia A/B prophylaxis, highlighting its efficacy and safety in the BASIS trial. It also covers matched-donor allogeneic CD19 CAR-T for adult B-ALL and introduces the CLIPI prognostic index for cutaneous lymphomas, aiding…